Eli Lilly Strikes $2.88 Billion Deal to Buy Merida Biosciences
Eli Lilly (LLY) has agreed to acquire Merida Biosciences for up to $2.875 billion in cash, as it see
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
